4//SEC Filing
Ackermann Michael 4
Accession 0001209191-21-050177
CIK 0001819790other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 4:16 PM ET
Size
7.8 KB
Accession
0001209191-21-050177
Insider Transaction Report
Form 4
Ackermann Michael
Director10% Owner
Transactions
- Sale
Common Stock
2021-08-05$25.00/sh−1,183$29,575→ 1,231,998 total - Sale
Common Stock
2021-08-05$25.00/sh−100$2,501→ 1,231,898 total - Sale
Common Stock
2021-08-05$25.01/sh−100$2,501→ 1,231,798 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001791249
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 4:16 PM ET
- Size
- 7.8 KB